Citation: Ke. Kinnamon et al., TRYPANOSOMA-CRUZI - A NOVEL CHEMICAL CLASS (NITROBENZOFURANS) ACTIVE AGAINST INFECTIONS OF MICE (MUS MUSCULUS), Experimental parasitology, 89(2), 1998, pp. 251-256
Citation: Ke. Kinnamon et al., ACTIVITY OF ANTICANCER COMPOUNDS AGAINST TRYPANOSOMA CRUZI-INFECTED MICE, The American journal of tropical medicine and hygiene, 58(6), 1998, pp. 804-806
Authors:
STEWART JM
GERA L
CHAN DC
WHALLEY ET
HANSON WL
ZUZACK JS
Citation: Jm. Stewart et al., LONG-ACTING, ORALLY-ACTIVE BRADYKININ ANTAGONISTS FOR A WIDE-RANGE OFAPPLICATIONS, Immunopharmacology, 36(2-3), 1997, pp. 167-172
Citation: Jk. Relton et al., CP-0597, A SELECTIVE BRADYKININ B-2 RECEPTOR ANTAGONIST, INHIBITS BRAIN INJURY IN A RAT MODEL OF REVERSIBLE MIDDLE CEREBRAL-ARTERY OCCLUSION, Stroke, 28(7), 1997, pp. 1430-1436
Citation: Ke. Kinnamon et al., IN PURSUIT OF DRUGS FOR AMERICAN TRYPANOSOMIASIS - EVALUATION OF SOMESTANDARDS IN A MOUSE MODEL, Proceedings of the Society for Experimental Biology and Medicine, 216(3), 1997, pp. 424-428
Citation: Ke. Kinnamon et al., CHAGAS-DISEASE - A SEARCH FOR TREATMENT AND A QUESTION - SHOULD THE DISEASE BE OF MILITARY CONCERN, Military medicine, 162(8), 1997, pp. 527-532
Citation: Et. Whalley et al., ORAL ACTIVITY OF PEPTIDE BRADYKININ ANTAGONISTS FOLLOWING INTRAGASTRIC ADMINISTRATION IN THE RAT, Canadian journal of physiology and pharmacology, 75(6), 1997, pp. 629-632
Authors:
STEWART JM
GERA L
CHAN DC
WHALLEY ET
HANSON WL
ZUZACK JS
Citation: Jm. Stewart et al., POTENT, LONG-ACTING BRADYKININ ANTAGONISTS FOR A WIDE-RANGE OF APPLICATIONS, Canadian journal of physiology and pharmacology, 75(6), 1997, pp. 719-724
Citation: Ke. Kinnamon et al., EVIDENCE THAT CERTAIN 8-AMINOQUINOLINES ARE POTENTIALLY EFFECTIVE DRUGS AGAINST CHAGAS-DISEASE, Annals of tropical medicine and parasitology, 91(2), 1997, pp. 147-152
Authors:
STEWART JM
GERA L
WHALLEY ET
HANSON WL
ZUZACK JS
Citation: Jm. Stewart et al., A POTENT, ORALLY-ACTIVE, LONG-ACTING BRADYKININ PEPTIDE ANTAGONIST FOR BOTH B1 AND B2 RECEPTORS, The FASEB journal, 10(3), 1996, pp. 3273-3273
Authors:
HANSON WL
MCCULLOUGH RG
SELIG WM
WIECZOREK M
ROSS S
WHALLEY ET
STEWART JM
GERA L
Citation: Wl. Hanson et al., IN-VIVO PHARMACOLOGICAL PROFILE OF NOVEL, POTENT, STABLE BK ANTAGONISTS AT B-1 AND B-2 RECEPTORS, Immunopharmacology, 33(1-3), 1996, pp. 191-193
Citation: Ke. Kinnamon et al., PRIMAQUINE ANALOGS THAT ARE POTENT ANTI-TRYPANOSOMA CRUZI AGENTS IN AMOUSE MODEL, Annals of tropical medicine and parasitology, 90(5), 1996, pp. 467-474
Citation: La. Lamb et Wl. Hanson, COMPARISON OF THE EFFICACY OF WR-6026 AND MEGLUMINE ANTIMONIATE (GLUCANTIME) IN EUTHYMIC AND ATHYMIC MICE INFECTED WITH LEISHMANIA (L) DONOVANI, The FASEB journal, 9(3), 1995, pp. 230-230
Authors:
HANSON WL
BOGGS DF
KAY JM
HOFMEISTER SE
WAGNER WW
Citation: Wl. Hanson et al., COLLATERAL VENTILATION AND PULMONARY ARTERIAL SMOOTH-MUSCLE IN THE COATI, Journal of applied physiology, 74(5), 1993, pp. 2219-2224
Authors:
CHERONIS JC
GOODFELLOW VS
LOY SD
MARATHE M
ELDER M
HANSON WL
WHALLEY ET
Citation: Jc. Cheronis et al., IN-VITRO AND IN-VIVO ACTIVITY OF A PERIPHERALLY ACTING MU-OPIOID RECEPTOR AGONIST BK(2) RECEPTOR ANTAGONIST HETERODIMER, British Journal of Pharmacology, 109, 1993, pp. 160000018-160000018